Showing results (421-430 of 546) with videos related to
Sort By:
Pageof 55
The Journal of Experimental Medicine|February 5, 2014
Monovalent engagement of the BCR activates ovalbumin-specific transnuclear B cellsAna M Avalos, Angelina M Bilate, Martin D Witte, et al.Reviews on Environmental Health|November 28, 2015
EUROPAEM EMF Guideline 2015 for the prevention, diagnosis and treatment of EMF-related health problems and illnessesIgor Belyaev, Amy Dean, Horst Eger, et al.Physics and Imaging in Radiation Oncology|July 3, 2025
A method for sensitivity analysis of automatic contouring algorithms across different contrast weightings using synthetic magnetic resonance imagingLucas McCullum, Zayne Belal, Warren Floyd, et al.Breast Cancer Research and Treatment|June 14, 2024
The REMAR (Rhein-Main-Registry) real-world study: prospective evaluation of the 21-gene breast recurrence score® assay in addition to Ki-67 for adjuvant treatment decisions in early-stage breast cancerChristian Jackisch, Louiza Anastasiadou, Sebastian Aulmann, et al.Medrxiv : the Preprint Server for Health Sciences|January 20, 2025
A Method for Sensitivity Analysis of Automatic Contouring Algorithms Across Different MRI Contrast Weightings Using SyntheticMRLucas McCullum, Zayne Belal, Warren Floyd, et al.Frontiers in Oncology|May 3, 2024
App-based support for breast cancer patients to reduce psychological distress during therapy and survivorship - a multicentric randomized controlled trialJosefine Wolff, Svenja Seidel, Pia Wuelfing, et al.Breast (Edinburgh, Scotland)|September 10, 2023
Anti-hormonal maintenance treatment with the CDK4/6 inhibitor ribociclib after 1st line chemotherapy in hormone receptor positive / HER2 negative metastatic breast cancer: A phase II trial (AMICA)Thomas Decker, Kerstin Lüdtke-Heckenkamp, Luidmila Melnichuk, et al.Psychological Medicine|September 28, 2021
The priming effect of repetitive transcranial magnetic stimulation on clinical response to electroconvulsive therapy in treatment-resistant depression: a randomized, double-blind, sham-controlled studyMaud Rothärmel, Pierre Quesada, Thomas Husson, et al.BMC Cancer|August 27, 2018
RESPONDER - diagnosis of pathological complete response by vacuum-assisted biopsy after neoadjuvant chemotherapy in breast Cancer - a multicenter, confirmative, one-armed, intra-individually-controlled, open, diagnostic trialJoerg Heil, Peter Sinn, Hannah Richter, et al.Eclinicalmedicine|December 2, 2022
Patient-reported outcomes for the Intergroup Sentinel Mamma study (INSEMA): A randomised trial with persistent impact of axillary surgery on arm and breast symptoms in patients with early breast cancerToralf Reimer, Angrit Stachs, Kristina Veselinovic, et al.Pageof 55